Foamy virus vector-mediated gene transfer into long-term HSC in the gene therapy for primary immunodeficiencies.
Project/Area Number |
25860836
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Pediatrics
|
Research Institution | National Research Institute for Child Health and Development |
Principal Investigator |
UCHIYAMA TORU 独立行政法人国立成育医療研究センター, 成育遺伝研究部, 室長 (10436107)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | FVベクター / X連鎖重症複合免疫不全症 / 遺伝子治療 / X連鎖重症複合免役不全症 / dNLnk |
Outline of Final Research Achievements |
Using Foamy virus-based (FV) vector, we have established the gene transfer system for X-linked severe combined immunodeficiency (X-SCID). We constructed FV vector containing human γc under the control of A2UCOE for stable gene expression, and transduced the bone marrow cells from X-SCID mice. Gene transduced cells were transplanted into NOD/SCID-γc null mice, which provided high level of engraftment of hematopoietic cells. In transplanted mice, splenic T cells showed the improvement in proliferation and IL-2 production in response to anti-CD3 stimulation, and serum levels of IgM, IgA and IgG were also elevated. These results revealed the functional reconstitution of immune system. Analysis of vector integration demonstrated that FV integration sites were slightly less likely to be located within or near transcriptional start sites than retroviral vector (RV) integration sites. These data suggest that FV vector is a safer system than RV vector in stem cell gene therapy for X-SCID.
|
Report
(3 results)
Research Products
(18 results)
-
[Journal Article] Interstitial Lung Disease with Multiple Microgranulomas in Chronic Granulomatous Disease.2014
Author(s)
Kawai T, Watanabe N, Yokoyama M, Nakazawa Y, Goto F, Uchiyama T, Higuchi M, Maekawa T, Tamura E, Nagasaka S, Hojo M, Onodera M
-
Journal Title
Journal of Clinical Immunology
Volume: 34
Issue: 8
Pages: 933-940
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.2014
Author(s)
2.Looi CY, Sasahara Y, Watanabe Y, Sato M, Hakozaki I, Uchiyama M, Wong WF, Uchiyama T, Kumaki S, Tsuchiya S, Kure S
-
Journal Title
International Immnology
Volume: 26
Issue: 6
Pages: 341-352
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector2013
Author(s)
Horino S, Uchiyama T, So T, Nagashima H, Sun SL, Sato M, Asao A, Haji Y, Sasahara Y, Candotti F, Tsuchiya S, Kure S, Sugamura K, and Ishii N
-
Journal Title
PLoS ONE
Volume: 8
Issue: 8
Pages: e71594-e71594
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.2013
Author(s)
Watanabe Y, Sasahara Y, Satoh M, Looi CY, Katayama S, Suzuki T, Suzuki N, Ouchi M, Horino S, Moriya K, Nanjyo Y, Onuma M, Kitazawa H, Irie M, Niizuma H, Uchiyama T, Rikiishi T, Kumaki S, Minegishi M, Wada T, Yachie A, Tsuchiya S, Kure S.
-
Journal Title
Eur J Haematol
Volume: 91
Issue: 3
Pages: 242-248
DOI
Related Report
Peer Reviewed
-
[Journal Article] Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations2013
Author(s)
Kitazawa H, Moriya K, Niizuma H, Kawano K, Saito-Nanjo Y, Uchiyama T, Rikiishi T, Sasahara Y, Sakamoto O, Setoguchi Y, Kure S
-
Journal Title
Eur J Pediatr
Volume: 172(7)
Issue: 7
Pages: 953-7
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-